HIGHLIGHTS
- who: Mutagen sensitivity Bleomycin test and colleagues from the Department of Oncology, Semmelweis University, Budapest, Hungary have published the research work: of second cancer in younger adults with head and neck squamous cell cancer: 15-year results, in the Journal: (JOURNAL)
- what: The aim of this study was to determine the predictive value of mutagen sensitivity for the development of SPC in a group of HNSCC patients who were tested for mutagen sensitivity and treated between 1996 and 2006 at the National Institute of Budapest, Hungary .
- how: The authors studied the following risk . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.